Platelet aggregation may not be a prerequisite for collagen-stimulated platelet generation of nitric oxide

Citation
Cct. Smith et al., Platelet aggregation may not be a prerequisite for collagen-stimulated platelet generation of nitric oxide, BBA-GEN SUB, 1473(2-3), 1999, pp. 286-292
Citations number
33
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
ISSN journal
03044165 → ACNP
Volume
1473
Issue
2-3
Year of publication
1999
Pages
286 - 292
Database
ISI
SICI code
0304-4165(199912)1473:2-3<286:PAMNBA>2.0.ZU;2-I
Abstract
By determining the sum of the supernatant concentrations of nitrite and nit rate the stimulated generation of nitric oxide (NO) by human washed platele ts induced by a range of fibrillar collagen concentrations (0.0156-25 mu g ml(-1)) was investigated. Platelet serotonin (5-hydroxytryptamine, 5-HT) ef flux and platelet aggregation were also measured. Under resting conditions (0 mu g ml(-1) collagen) platelet NO release was equivalent to 1.06 +/- 0.1 7 nmol per 10(8) platelets. Maximal NO release. equivalent to 2.1 +/- 0.37 nmol per 10(8) platelets, was observed with only 0.0625 pg ml(-1) collagen (P < 0.02, stimulated vs. resting release), higher collagen concentrations producing no further increases in platelet NO output. By contrast, maximal platelet aggregation and 5-HT efflux did not occur until collagen concentra tions of 2.5 mu g ml-(1) and 10-25 mu g ml(-1) respectively, had been achie ved. L-NAME (1 mmol 1(-1)) and L-NMMA (1 mmol 1(-1)) inhibited stimulated p latelet NO generation by 78 +/- 6% and 72%, respectively. Contrasting with fibrillar collagen, fibrillar beta-amyloid protein had no effect on platele t NO generation, or on 5-HT efflux or aggregation. These data perhaps indic ate that NO generation by human platelets is stimulated by concentrations o f fibrillar collagen insufficient to elicit an aggregatory response. Such a mechanism could operate in vivo to inhibit platelet aggregation which migh t otherwise be induced by low concentrations of circulating agonists. (C) 1 999 Elsevier Science B.V. All rights reserved.